Why Cardiovascular Systems, Inc. Shares Are Feeling Pumped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Cardiovascular Systems (NASDAQ: CSII  ) , a medical device company focused on minimally invasive cardiovascular solutions, advanced by as much as 19% after reporting better-than-expected second-quarter earnings results.

So what: For the quarter, Cardiovascular Systems delivered a 28% increase in revenue to $32.3 million as its net loss per share widened to $0.32 from $0.28 in the year-ago period. Despite the wider loss from last year, this was a $0.02 per share narrower loss than Wall Street had anticipated, while revenue was $1.7 million higher than expected. Looking toward the third quarter, Cardiovascular Systems offered a mixed picture with an EPS loss forecast of $0.31 to $0.34, which is notably worse than the current consensus that calls for an EPS loss of $0.26, but is also projecting a market-topping $33 million to $34.5 million in revenue compared to the consensus estimate of $32.7 million.

Now what: The results aren't really that striking on the surface, so it appears that investors are reacting to the positive tone behind the launch of the company's Diamondback 360 Coronary Orbital Atherectomy System following its FDA approval in October to treat cases of severely calcified arteries. The company noted that more than 200 patients have now been treated with this new OAS technology and estimates the market opportunity for its product could be as high as $1.5 billion. While that figure is bound to stir the pot of optimists, the bottom-line results clearly show Cardiovascular Solutions has a long way to go in order to be profitable. With that being said, while the technology behind the company is "cool," the valuation simply isn't, and I'd suggest sticking to the sidelines until it narrows its losses significantly.

Cardiovascular Systems may be soaring today, but it'll probably have a hard time keeping pace with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 31, 2014, at 2:01 AM, morten1952 wrote:

    Remember Cardiovascular Systems for the time being is only marketing and selling their products in the USA. The rest of the world is untapped.

Add your comment.

DocumentId: 2817136, ~/Articles/ArticleHandler.aspx, 4/18/2014 8:22:27 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement